Artrya
About Artrya
Artrya is an AI-driven MedTech company dedicated to transforming the diagnosis and management of coronary artery disease (CAD), the leading cause of death globally. Their flagship product, Artrya Salix, is an innovative diagnostic support solution that leverages artificial intelligence to analyze coronary computed tomography angiography (CCTA) images. This platform provides physicians with rapid, accurate, and non-invasive insights into arterial plaque features, including the identification of vulnerable plaque, which is often missed by traditional diagnostic methods.
The company’s mission is to shift the paradigm of cardiac care from a symptom-based approach to a preventative one, enabling earlier detection and more precise risk stratification of chest pain patients. By integrating AI into clinical workflows, Artrya Salix aims to enhance diagnostic confidence, improve patient outcomes through timely intervention, and optimize operational efficiency within healthcare systems by reducing reporting times and potentially lowering unnecessary costs associated with over-testing. Artrya is also exploring AI applications for non-invasive blood flow simulation to further enhance diagnostic capabilities.
Focus Areas
Business Intelligence
| Key Investors | Alium Capital, Pengana Capital Ltd, Richcab Pty Ltd, Netwealth Investments Ltd, Regal Funds Management Pty Ltd, Wilson Asset Management (International) Pty Ltd, Paradice Investment Management Pty Ltd, Mutual Trust Pty Ltd |
| Partnerships | Tanner Health, Northeast Georgia Health System (NGHS), Cone Health, Sonic Healthcare |
| Acquisitions | None |
| Technology | Cloud-based, AI-enabled software, machine learning to CT coronary angiography images, AI-driven CCTA image analysis technology, Salix platform |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
Artrya Salix empowers physicians with rapid, AI-driven CCTA analysis, delivering comprehensive plaque characterization (including vulnerable plaque features like low attenuation plaque) and stenosis assessment within minutes. Leverage its near real-time results for accelerated patient triage, especially for chest pain patients, to reduce unnecessary hospitalizations and guide timely, personalized treatment or preventative care. The intuitive 3D heart model and detailed reports can significantly enhance patient communication and shared decision-making. Its integrated workflow streamlines the diagnostic process, allowing for greater efficiency and potentially increasing the number of scans processed daily.
Artrya Salix is a cloud-based, browser-based platform designed for seamless integration with existing hospital and imaging clinic systems, including Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMR). It requires no capital equipment investment, hardware installation, or downloads, ensuring simple deployment and compatibility with leading CCTA scanners. This allows clinicians to incorporate AI-supported patient scans directly into their current workflows.
What the Web Says
Artrya is a medical technology company that utilizes AI to analyze CT scans for the detection and management of coronary artery disease, aiming to improve diagnostic capabilities and patient outcomes. Their flagship product, Artrya Salix, focuses on identifying high-risk plaque that traditional methods might miss, and aims to reduce reporting times significantly. While the technology is considered innovative with significant potential to transform cardiovascular care, the company is still in the process of converting its technically impressive platform into a scalable, revenue-generating business.
Overall: MixedStrengths
- Innovative AI-driven technology for cardiovascular diagnostics.
- Aims to enhance early detection of coronary artery disease and high-risk plaque.
- Potential to reduce reporting times for CT scans from up to 30 minutes to less than two minutes.
- Designed to improve accuracy, speed, and clinical confidence in identifying vulnerable plaque.
- Can help minimize unwarranted hospital stays and associated healthcare costs by accurately identifying low-risk patients.
- Supports personalized treatment plans and shared decision-making between physicians and patients.
Limitations
- Limited reviews available on major platforms like G2 and Capterra, making it difficult to gauge widespread user satisfaction.
- Faced challenges with FDA approval for its Salix software, with the initial application being rejected due to not being deemed substantially equivalent to a predicate device.
- The company is at a crossroads, needing to demonstrate successful commercial adoption and revenue generation beyond its technological promise.
- Some Reddit discussions about similar AI health tech companies (Arteria.ai) mention rescinded job offers due to financial issues, which could indicate potential instability in the broader AI health tech startup landscape.
- The advanced nature of the AI software has presented regulatory challenges regarding the level of human oversight required.
Based on reviews from: Slashdot, G2, Capterra, The Investor Standard, Artrya Website, BioWorld, YouTube, Reddit
Last updated: 2026-07-18
Videos
News, demos, and interviews about Artrya.
Videos load interactively. If none appear, search YouTube for Artrya →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]